UBS Group’s Apex Technology Acquisition Corporation Unit APXTU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-688
Closed -$9K 10813
2021
Q2
$9K Sell
688
-288
-30% -$3.5K ﹤0.01% 8211
2021
Q1
$0 Buy
976
+308
+46% +$5K ﹤0.01% 9829
2020
Q4
$11K Sell
668
-533
-44% -$7.82K ﹤0.01% 7458
2020
Q3
$14K Buy
1,201
+200
+20% +$2.24K ﹤0.01% 6613
2020
Q2
$11K Sell
1,001
-8
-0.8% -$84 ﹤0.01% 6977
2020
Q1
$10K Sell
1,009
-191
-16% -$2.01K ﹤0.01% 6958
2019
Q4
$13K Sell
1,200
-2,000
-63% -$20.6K ﹤0.01% 7165
2019
Q3
$33K Buy
+3,200
New +$32.5K ﹤0.01% 6438

UBS Group's APXTU Position: Q3 2021 in Review

UBS Group sold out of Apex Technology Acquisition Corporation Unit (APXTU) in Q3 2021, closing a stake of 688 shares — an estimated $9K sold.

UBS Group first reported a position in APXTU in Q3 2019 and held it in 8 quarters. The position peaked at $33K in Q3 2019. 0 funds tracked by Wall St. Rank hold APXTU as of Q3 2021.

  • UBS Group reported no remaining Apex Technology Acquisition Corporation Unit position as of Q3 2021 after selling out during the quarter.
  • UBS Group sold 688 Apex Technology Acquisition Corporation Unit shares in Q3 2021, an estimated $9K.
  • UBS Group first reported a position in Apex Technology Acquisition Corporation Unit in Q3 2019 and held it in 8 quarters.
  • UBS Group's Apex Technology Acquisition Corporation Unit position peaked at $33K in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Apex Technology Acquisition Corporation Unit as of Q3 2021.

Based on UBS Group's 13F filing for Q3 2021, filed 15 Nov 2021.